HCA Healthcare, Inc. $HCA Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Key Points

• The **Fjarde AP Fonden Fourth Swedish National Pension Fund** sold **11,000 shares** of HCA Healthcare, reducing its stake by **29%**, leaving it with **26,869 shares worth $9.29 million**.
• Several institutional investors have significantly increased their stakes in HCA, with **GAMMA Investing LLC** raising its position by **40,527.3%** to over **1.7 million shares worth nearly $5.89 billion**.
• The company's earnings report showed a **$6.84 EPS**, exceeding expectations, while HCA Healthcare also announced a quarterly dividend of **$0.72 per share** with a yield of **0.7%**.

Fjarde AP Fonden Fourth Swedish National Pension Fund lowered its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 29.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 26,869 shares of the company's stock after selling 11,000 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in HCA Healthcare were worth $9,285,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Boston Partners boosted its holdings in HCA Healthcare by 31.5% in the first quarter. Boston Partners now owns 164,021 shares of the company's stock valued at $56,677,000 after purchasing an additional 39,250 shares during the last quarter. Leith Wheeler Investment Counsel Ltd. boosted its holdings in HCA Healthcare by 5.3% in the first quarter. Leith Wheeler Investment Counsel Ltd. now owns 21,230 shares of the company's stock valued at $7,336,000 after purchasing an additional 1,078 shares during the last quarter. National Pension Service boosted its holdings in HCA Healthcare by 7.6% in the first quarter. National Pension Service now owns 613,611 shares of the company's stock valued at $212,033,000 after purchasing an additional 43,320 shares during the last quarter. LGT Group Foundation boosted its holdings in HCA Healthcare by 4.0% in the first quarter. LGT Group Foundation now owns 19,268 shares of the company's stock valued at $6,658,000 after purchasing an additional 742 shares during the last quarter. Finally, LGT Fund Management Co Ltd. lifted its holdings in HCA Healthcare by 4.4% during the 1st quarter. LGT Fund Management Co Ltd. now owns 27,352 shares of the company's stock worth $9,451,000 after buying an additional 1,153 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

HCA traded up $7.4980 during trading hours on Wednesday, hitting $410.1880. The company's stock had a trading volume of 1,639,519 shares, compared to its average volume of 1,471,573. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $95.98 billion, a PE ratio of 17.24, a PEG ratio of 1.27 and a beta of 1.39. The company has a 50-day simple moving average of $372.57 and a 200 day simple moving average of $352.94.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same period last year, the firm earned $5.50 EPS. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is presently 12.11%.

Wall Street Analyst Weigh In

HCA has been the subject of several research reports. Robert W. Baird lifted their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. Barclays decreased their target price on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research report on Monday, July 28th. Finally, JPMorgan Chase & Co. raised their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $398.58.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.